Home Online Features Chromatin Bioscience's synthetic promoter supports EsoBiotec's ESO-T01 CAR-T therapy as it enters the clinic
Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic
Hand-out
Press Releases
Chromatin Bioscience  
January 15, 2025

Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic

EDINBURGH, Scotland, Jan. 15, 2025 /PRNewswire/ -- Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical

logo salamanca press

Salamanca Press

email salamanca press
Local & Social